Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Accumulated Depreciation (2018 - 2025)

iBio (IBIO) has disclosed Accumulated Depreciation for 8 consecutive years, with $1.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Accumulated Depreciation changed N/A to $1.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.6 million, a N/A change, with the full-year FY2025 number at $1.5 million, up 47.87% from a year prior.
  • Accumulated Depreciation was $1.6 million for Q3 2025 at iBio, up from $1.5 million in the prior quarter.
  • In the past five years, Accumulated Depreciation ranged from a high of $2.8 million in Q1 2022 to a low of $400000.0 in Q2 2023.
  • A 5-year average of $1.3 million and a median of $1.3 million in 2024 define the central range for Accumulated Depreciation.
  • Peak YoY movement for Accumulated Depreciation: skyrocketed 152.75% in 2024, then skyrocketed 47.87% in 2025.
  • iBio's Accumulated Depreciation stood at $1.5 million in 2021, then soared by 80.08% to $2.8 million in 2022, then crashed by 73.56% to $729000.0 in 2023, then skyrocketed by 71.88% to $1.3 million in 2024, then increased by 29.13% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Accumulated Depreciation are $1.6 million (Q3 2025), $1.5 million (Q2 2025), and $1.4 million (Q1 2025).